Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Lonsurf
Sort By
Newest First
Sign in
1 / 1
1 / 1
Oncology
Taiho Oncology Announces Positive Topline Results from Pivotal Phase 3 Trial of LONSURF® (trifluridine/tipiracil) in Metastatic Gastric Cancer
Taiho Oncology, Inc.
PR-M05-18-NI-045
May 11, 2018
Endpoint
Phase III Study Evaluating the Efficacy and Safety of Lonsurf in Patients with Metastatic Gastric Cancer Meets Primary Endpoint
Servier
PR-M05-18-NI-040
May 10, 2018
